Pinsent Masons advises on James Hambro & Partners and Calkin Pattinson Merger

20 Aug 2012 | 12:02 pm | 1 min. read

International law firm Pinsent Masons has advised Calkin Pattinson on its merger with James Hambro & Partners (James Hambro). The combined group will manage in excess of £1 billion assets.

James Hambro, the independent private asset management partnership, which manages funds on behalf of private clients and charities, has merged with Calkin Pattinson, a leading financial planner for high net worth clients. The group will trade under the James Hambro brand.

Founded in 2009, James Hambro manages discretionary investment portfolios for 102 families, charities and trusts – with around £400 million assets under management and administration. Calkin Pattinson advises 2,000 private clients and charities on financial planning issues, and manages around £600 million assets. The merged group will combine financial planning and discretionary portfolio management and is ideally positioned to attract new clients.

James Hambro, Chairman, James Hambro & Partners, commented: “In an increasingly complex financial environment, the ability to offer a broader range of services to clients will be important.“

Charles Calkin, Chairman and Chief Executive, Calkin Pattinson, added: “James Hambro & Partners offers an excellent investment capability coupled with a strong performance record.”  

On completion of the deal Charles and Paul Calkin will become partners in James Hambro.

Andy Steel, who will lead the combined James Hambro Group as Chief Executive said: “We’ve attracted a considerable amount of business from major banks in the last year or so and we expect this to accelerate with a broader service offering in place. In a post-RDR world the combination of independent financial advice with a highly tailored portfolio management capability should further increase our ability to attract business”.

The Pinsent Masons deal team was lead by Corporate Partner Andrew Kerr, assisted primarily by Adrienne Murdoch and James Foster (corporate), and John Christian and Richard Fullilove (tax).

Commenting on the deal Andrew said: "We are delighted to have assisted Calkin Pattinson with this strategic merger. The combined firm is now well positioned to take advantage of the post-RDR world."

Benoit Guerin at Hines & Associates provided corporate finance advice.

Latest press releases

Show me all press releases

Pinsent Masons MPillay advises SUSI Partners on investment in Alba Renewables

Law firm Pinsent Masons MPillay has advised Swiss-based infrastructure investment manager SUSI Partners on its investment in Alba Renewables to build a renewable energy infrastructure business focused on The Philippines.

Pinsent Masons advises La Bottega on Australian acquisition

Multinational law firm Pinsent Masons has advised Italian producer of hotel essentials La Bottega on its acquisition of a majority stake in Australian company Vanity Group.

Pinsent Masons promotes 22 to its partnership

Multinational law firm Pinsent Masons has boosted its global professional services capabilities with the promotion of 22 new partners.

People who viewed this press release also viewed

Show me all press releases

Pinsent Masons MPillay advises SUSI Partners on investment in Alba Renewables

Law firm Pinsent Masons MPillay has advised Swiss-based infrastructure investment manager SUSI Partners on its investment in Alba Renewables to build a renewable energy infrastructure business focused on The Philippines.

Pinsent Masons advises Bestinver Infra, FCR on acquisition of remaining shares in Irish toll road concession & operation companies

Pinsent Masons has advised Bestinver Infra, FCR on the acquisition of the remaining shares in N6 (Concession) Holdings Limited and N6 (Operations) Ltd, with Japanese co-investor Daiwa Energy & Infrastructure Co. Ltd.

Pinsent Masons advises Sandoz on acquisition of remaining shares in Rowex Joint Venture

Multinational law firm Pinsent Masons has advised Sandoz on the acquisition of the remaining shares in Rowex Limited, a joint venture in Ireland between Sandoz and Rowa Pharmaceuticals.

For all media enquiries, including arranging an interview with one of our spokespeople, please contact the press office on

+44 (0)20 7418 8199 or 

Location contacts

We are processing your request. \n Thank you for your patience. An error occurred. This could be due to inactivity on the page - please try again.